Clinical Studies & Trials

ARDL: A central biochemistry laboratory

Selected ARDL trial studies for FY16 - FY20

 Epidemiology of Diabetes Interventions and Complications
EDIC (4/30/17): Diabetes epidemology, intervention, complications
EDIC hearing study (8/31/16): Ancillary to EDIC, hearing measures
EDIC c-peptide study (8/31/16): Ancillary to EDIC, c pep insulin precursor measures
 
Michael Steffes, MD., PhD., Principal Investigator 

   National Health and Nutrition Examination Survey

NHANES Central Biochemistry Laboratory (9/2021): National Health and Nutrition Examination Survey

Anthony Killeen, MD., PhD., Principal Investigator 

NHANES Lipids (4/14/19): National Health and Nutrition Examination Survey

John Eckfeldt, MD., PhD., Principal Investigator 

 


 Multi-Ethnic Study of Atherosclerosis

MESA Kidney (8/31/16): Multi-Ethnic Study of Atherosclerosis 

John Eckfeldt, MD., PhD., Principal Investigator 

MESA 2 Central Lab (8/14/15): Multi ethnic atherosclerosis
MESA 2 Lipids (8/14/15): Multi ethnic atherosclerosis
 
Michael Tsai, PhD., Principal Investigator 

 


 Systolic Blood Pressure Intervention Trial

Sprint (9/30/18)-Systolic Blood Pressure Intervention Trial: Blood pressure intervention trial

Anthony Killeen, MD., PhD., Principal Investigator 

 


 Atherosclerosis Risk in Communities

ARIC (12/31/2020)-- Diabetes and Prediabetes in Older Adults in ARIC (Atherosclerosis Risk in Communities)

Amy Saenger, PhD., DABCC, Principal Investigator 

 


Hispanic Community Health Study / Study of Latinos 

HCHS Visit 2 (Hispanic Community Health Study)(5/31/2019): Hispanic acculturation and disease development / SOL Youth (11/30/15): Study of Latino children's overall health

John Eckfeldt, MD., PhD., Principal Investigator 
Bharat Thyagarajan, MD., PhD., MPH, Principal Investigator

 


 Health and Retirement Study

HRS (12/31/17): Health in retirement age population

Bharat Thyagarajan, MD., PhD., MPH, Principal Investigator 


Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study 

GRADE (7/31/17): Glycemic reduction in diabetes effectiveness / GRADE - EDS substudy (3/31/20): Ancillary to GRADE

Michael Steffes, MD., PhD., Principal Investigator


  Preventing Early Renal Loss

PERL (6/30/18): Project with Joslin Diabetes

Amy Karger, MD., PhD., Principal Investigator 


 

ASSESS (6/30/19): Long term outcomes in acute kidney injury / ASSESS-AKI ancillary (Liu) (6/30/18): Ancillary to ASSESS

Michael Steffes, MD., PhD., Principal Investigator